Rapid Bacteria Identification and Antimicrobial Susceptibility Testing via 5‐Min Fluorescence In Situ Hybridization
Small · 2026-01 · 22 (3)
DOI: 10.1002/smll.202510292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 08.12.2025. Verfasst von Lai Wei und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA. Hauptthemen laut MEDLINE: In Situ Hybridization, Fluorescence, Bacteria, Anti-Bacterial Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Accurate and timely diagnosis of infections, including pathogen detection and antibiotic susceptibility testing (AST), is essential to effective disease management and combating antibiotic resistance. Here, SWIFT‐FISH (Sensitive, Wash‐free, Immediate, microFluidic, Thermal permeabilization‐facilitated Fluorescence In Situ Hybridization), a novel diagnostic platform enabling bacterial identification (ID) in ≈5 min is reported, complemented by rapid AST. SWIFT‐FISH significantly accelerates the conventional FISH workflow through transient thermal permeabilization, allowing intracellular hybridization of fluorescent peptide nucleic acid (PNA) probes to bacterial 16S ribosomal RNA (rRNA) without the conventional fixation step. SWIFT‐FISH is then directly detected in solution within a continuous‐flow microfluidic platform equipped with in‐line single‐cell resolution multi‐color laser‐induced fluorescence (LIF) detection. This approach boosts the cell‐to‐background ratio, which obviates the conventional washing step, while also enabling continuous cell delivery as a means for improving detection sensitivity. Using 3 broad‐based probes and incorporating machine learning–based analysis, SWIFT‐FISH demonstrates scalable identification of 6 bacterial species with ≈99% accuracy. Finally, by quantifying bacterial proliferation, SWIFT‐FISH readily enables rapid phenotypic AST with ≈1 h turnaround time. SWIFT‐FISH thus represents a simple, rapid, sensitive, and versatile diagnostic technology with significant potential to enhance clinical microbiology and antibiotic stewardship.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Mechanical Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA.
- Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA.
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21218, USA.
- Institute for Nanobiotechnology, Johns Hopkins University, Baltimore, MD, 21218, USA.
ORCID-Profile: Lai Wei, Tza-Huei Wang
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Wei, L., Shao, F., Dharmasena, S., Li, S., Yang, J., Mirmiran, A., Zhang, P., Lewis, S., Carroll, K. C., Hsieh, K., & Wang, T. H. (2026). Rapid Bacteria Identification and Antimicrobial Susceptibility Testing via 5‐Min Fluorescence In Situ Hybridization. Small, 22(3). https://doi.org/10.1002/smll.202510292
Vancouver
Wei L, Shao F, Dharmasena S, Li S, Yang J, Mirmiran A, et al. Rapid Bacteria Identification and Antimicrobial Susceptibility Testing via 5‐Min Fluorescence In Situ Hybridization. Small. 2026;22(3). doi:10.1002/smll.202510292
BibTeX
@article{Wei2026,
author = {Wei, Lai and Shao, Fangchi and Dharmasena, Sayuni and Li, Sixuan and Yang, Jiyuan and Mirmiran, Arman and Zhang, Pengfei and Lewis, Shawna and Carroll, Karen C and Hsieh, Kuangwen and Wang, Tza-Huei},
title = {Rapid Bacteria Identification and Antimicrobial Susceptibility Testing via 5‐Min Fluorescence In Situ Hybridization},
journal = {Small},
year = {2026},
volume = {22},
number = {3},
doi = {10.1002/smll.202510292}
}
EUVIMED